25-hydroxyvitamin D dissociation agent as well as preparation method and application thereof

The invention discloses a 25-hydroxyvitamin D dissociation agent which is characterized by comprising the following components: 10 to 500 mM of PBS (Phosphate Buffer Solution), 0.005 to 0.05 g/mL of n-octyl-beta-D-maltoside, 0.01 to 0.1 g/mL of 3-[(3-cholesterol aminopropyl) dimethylamino]-2-hydroxy-1-propanesulfonic acid, 0.001 to 0.01 g/mL of lauryl sodium sulfate, 0.001 to 0.01 g/mL of BSA (Bovine Serum Albumin), 0.001 to 0.01 g/mL of sodium chloride and 0.01 to 1 percent of PC300, and the pH (Potential of Hydrogen) is 6.0 to 8.0. The invention has no toxic effect on human body, and has no direct or indirect toxic harm and risk to users and producers; most of the components are novel efficient descaling surfactants, and the protein dissociation effect is obvious. 本发明公开了一种25-羟基维生素D解离剂，其特征在于，包括如下组分：10-500mM PBS、0.005-0.05g/mL正辛基-β-D-麦芽糖苷、0.01-0.1g/mL 3-[(3-胆固醇氨丙基)二甲基氨基]-2-羟基-1-丙磺酸、0.001-0.01g/mL十二烷基硫酸钠、0.001-0.01g/mL BSA、0.001-0.01g/mL氯化钠，PC300 0.01-1％，pH6.0-8.0。本发明对人体无毒性作用，对使用者、生产者无直接或间接毒性危害和风险；本发明成分多数为新型高效